Jpmorgan Chase & CO Bio N Tech Se Transaction History

Jpmorgan Chase & CO

  • $1.23 Trillion
  • Q4 2024

A detailed history of Jpmorgan Chase & CO transactions in Bio N Tech Se stock. As of the latest transaction made, Jpmorgan Chase & CO holds 10,090 shares of BNTX stock, worth $1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,090
Previous 26,703 62.21%
Holding current value
$1 Million
Previous $3.17 Million 63.77%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
SELL
$99.72 - $122.68 $1.66 Million - $2.04 Million
-16,613 Reduced 62.21%
10,090 $1.15 Million
Q3 2024

Dec 26, 2024
SELL
$78.36 - $124.66 $1.8 Million - $2.87 Million
-23,016 Reduced 46.29%
26,703 $3.17 Million
Q3 2024

Nov 08, 2024
SELL
$78.36 - $124.66 $1.8 Million - $2.87 Million
-23,016 Reduced 46.29%
26,703 $3.17 Million
Q2 2024

Dec 26, 2024
BUY
$80.36 - $102.87 $1.85 Million - $2.37 Million
23,016 Added 86.19%
49,719 $4 Million
Q2 2024

Aug 12, 2024
BUY
$80.36 - $102.87 $3.39 Million - $4.33 Million
42,123 Added 554.54%
49,719 $4 Million
Q1 2024

Dec 26, 2024
SELL
$88.96 - $112.35 $1.7 Million - $2.15 Million
-19,107 Reduced 71.55%
7,596 $700,000
Q1 2024

May 10, 2024
SELL
$88.96 - $112.35 $20,549 - $25,952
-231 Reduced 2.95%
7,596 $700,000
Q4 2023

Dec 26, 2024
SELL
$90.91 - $112.75 $1.72 Million - $2.13 Million
-18,876 Reduced 70.69%
7,827 $826,000
Q4 2023

Feb 12, 2024
BUY
$90.91 - $112.75 $641,551 - $795,676
7,057 Added 916.49%
7,827 $826,000
Q3 2023

Nov 14, 2023
BUY
$98.5 - $125.08 $15,957 - $20,262
162 Added 26.64%
770 $83,000
Q2 2023

Aug 11, 2023
SELL
$102.58 - $129.66 $2.5 Million - $3.16 Million
-24,347 Reduced 97.56%
608 $65,000
Q1 2023

May 11, 2023
SELL
$122.57 - $153.67 $248,694 - $311,796
-2,029 Reduced 7.52%
24,955 $3.11 Million
Q4 2022

Feb 13, 2023
BUY
$118.43 - $186.05 $1.35 Million - $2.11 Million
11,365 Added 72.76%
26,984 $4.05 Million
Q3 2022

Nov 14, 2022
SELL
$127.65 - $183.11 $367,887 - $527,723
-2,882 Reduced 15.58%
15,619 $2.11 Million
Q2 2022

Aug 11, 2022
SELL
$123.25 - $186.24 $210,880 - $318,656
-1,711 Reduced 8.47%
18,501 $2.76 Million
Q1 2022

May 11, 2022
SELL
$126.25 - $231.85 $2.39 Million - $4.38 Million
-18,902 Reduced 48.33%
20,212 $3.45 Million
Q4 2021

Feb 10, 2022
BUY
$216.64 - $362.52 $672,233 - $1.12 Million
3,103 Added 8.62%
39,114 $10.1 Million
Q3 2021

Nov 12, 2021
BUY
$205.93 - $447.23 $7.42 Million - $16.1 Million
36,011 New
36,011 $9.83 Million

Others Institutions Holding BNTX

# of Institutions
364
Shares Held
39.6M
Call Options Held
3.01M
Put Options Held
2.01M
View Full List

About BioNTech SE

BNTX Quotes by TradingView
  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $24.1B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email